Patch testing in drug allergy

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 4, 2010, Pages 291-296

  Friedmann, Peter S ^a   Ardern Jones, Michael ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

diagnosis; drug allergy; drug hypersensitivity; patch tests; skin tests

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; DRUG;

DRUG ERUPTION; DRUG HYPERSENSITIVITY; EOSINOPHILIA; ERYTHEMA MULTIFORME; FIXED DRUG ERUPTION; HUMAN; PATCH TEST; PRIORITY JOURNAL; PUSTULOSIS; RASH; REVIEW; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; ADVERSE DRUG REACTION; DIAGNOSTIC USE; IMMUNOLOGY; PROCEDURES;

DRUG HYPERSENSITIVITY; HUMANS; PATCH TESTS; PHARMACEUTICAL PREPARATIONS; T-LYMPHOCYTES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

EID: 77954660067     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833aa54d     Document Type: Review

References (25)

1. Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34:377-395.
2. Pirmohamed M, James S, Meakin S, et al.. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 2004; 329:15-19. (Pubitemid 38869995)
3. Coombs RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, editors. Clinical aspects of immunology. Oxford, UK: Oxford University Press; 1968. pp. 576-596.
4. Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T-cell activation. In: Pichler WJ, editor. Drug hypersensitivity, 1st ed. Basel: Karger; 2007. pp. 168-189.
5. Friedmann PS, Pickard C, Ardern-Jones MR, Bircher AJ. Drug-induced exanthemata: a source of clinical and intellectual confusion. Eur J Dermatol 2010. [Epub ahead of print]
6. Barbaud A, ReichertPenetrat S, Trechot P, et al.. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139:49-58. (Pubitemid 28338063)
7. Barbaud A, GoncaloM, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:321-328. (Pubitemid 34056345)
8. Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148:434-443.
9. Nayak N, Friedmann PS, Healy E. Case 2. Bleomycin-induced flagellate dermatosis. Clin Exp Dermatol 2003; 28:105-106.
10. Cooper HL, Pickard C, Healy E, et al.. Antibiotic hypersensitivity mimicking recurrent endocarditis: identifying the culprit with the in vitro lymphocyte transformation test. QJM 2008; 101:67-68.
11. Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 2009; 29:517-535.
12. Goncalo M, Oliveira HS, Monteiro C, et al.. Allergic and systemic contact dermatitis from estradiol. Contact Dermatitis 1999; 40:58-59.
13. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005; 209:209-216.
14. Barbaud A, Trechot P, Reichert-Penetrat S, et al.. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:265-268. (Pubitemid 33032964)
15. Santiago F, Goncalo M, Vieira R, et al.. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 2010; 62:47-53.
16. Wolkenstein P, Chosidow O, Flechet ML, et al.. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35:234-236. (Pubitemid 26408155)
17. Torres MJ, Blanca M, Fernandez J, et al.. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972. (Pubitemid 37260337)
18. Elzagallaai AA, Knowles SR, Rieder MJ, et al.. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf 2009; 32:391-408.
19. Osawa J, Naito S, Aihara M, et al.. Evaluation of skin test reactions in patients with nonimmediate type drug eruptions. J Dermatol 1990; 17:235-239.
20. Viola M, Quaratino D, Gaeta F, et al.. Allergic reactions to antibiotics, mainly betalactams: facts and controversies. Eur Ann Allergy Clin Immunol 2005; 37:223-229.
21. Padial A, Antunez C, Blanca-Lopez N, et al.. Nonimmediate reactions to betalactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38:822-828.
22. Blanca-Lopez N, Zapatero L, Alonso E, et al.. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 2009; 64:229-233.
23. Torres MJ, Mayorga C, Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009; 19:80-90.
24. Bousquet PJ, Demoly P, Romano A, et al.. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy 2009; 64:194-203.
25. Hamanaka H, Mizutani H, Nouchi N, et al.. Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol. Clin Exp Dermatol 1998; 23:32-34.